Vaxcyte Market Cap from 2010 to 2024

PCVX Stock  USD 91.70  3.16  3.57%   
Vaxcyte Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 1.5 B in 2024. During the period from 2010 to 2024, Vaxcyte Market Cap regression line of annual values had r-squared of  0.26 and arithmetic mean of  1,572,897,123. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
2.8 B
Current Value
1.5 B
Quarterly Volatility
567 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 66.1 M, Interest Expense of 0.0 or Selling General Administrative of 63.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.16. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
  
Check out the analysis of Vaxcyte Correlation against competitors.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Latest Vaxcyte's Market Cap Growth Pattern

Below is the plot of the Market Cap of Vaxcyte over the last few years. It is Vaxcyte's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Vaxcyte Market Cap Regression Statistics

Arithmetic Mean1,572,897,123
Geometric Mean1,507,097,769
Coefficient Of Variation36.05
Mean Deviation368,655,313
Median1,356,972,226
Standard Deviation566,969,213
Sample Variance321454.1T
Range1.9B
R-Value0.51
Mean Square Error256311.2T
R-Squared0.26
Significance0.05
Slope64,595,208
Total Sum of Squares4500357.2T

Vaxcyte Market Cap History

20241.5 B
20232.8 B
20223.1 B
20211.2 B

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Market Cap, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Market Cap2.8 B1.5 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.